Rencofilstat
Rencofilstat (CRV431) is an orally active pan-cyclophilin inhibitor with IC50 values of 2.5 nM, 3.1 nM, 2.8 nM, 7.3 nM for Cyp A, CypB, Cyp D and Cyp G, respectively. Rencofilstat reduces fibrosis and tumor growth in models of chronic liver disease. Rencofilstat can be used for the study of nonalcoholic steatohepatitis (NASH), hepatocellular carcinoma and viral hepatitis-induced liver disease[1].
Product Specifications
CAS Number
1383420-08-3
Product Name Alternative
CRV431
UNSPSC
12352005
Target
Cyclophilin; Interleukin Related; Nuclear Factor of activated T Cells (NFAT) ; Sirtuin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rencofilstat.html
Purity
90.29
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
Molecular Formula
C67H122N12O13
Molecular Weight
1303.76
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Cyclophilin A; Cyclophilin B; Cyclophilin D; Cyclophilin G
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal VPS25 Antibody [FITC]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Human IL-2 R alpha & IL-2 R beta & IL-2 R gamma (Luc) HEK293 Reporter Cell